<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66-marinedrugs-17-00567">
 <label>66.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Derby</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lal</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Aravantinou</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kizima</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Barnable</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rodriguez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wesenberg</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ugaonkar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Levendosky</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo</article-title>
  <source>Nat. Commun.</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>3881</fpage>
  <pub-id pub-id-type="doi">10.1038/s41467-018-06349-0</pub-id>
  <?supplied-pmid 30250170?>
  <pub-id pub-id-type="pmid">30250170</pub-id>
 </element-citation>
</ref>
